Company Announcements

Ninety One UK Ltd - Form 8 (OPD) - Mediclinic International Plc

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the “Code”)

1.         KEY INFORMATION


(a) Full name of discloser:                         Ninety One UK Ltd

(b) Owner or controller of interests and short      Ninety One SA (Pty) Limited
positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is
insufficient. For a trust, the trustee(s), settlor
and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose    Mediclinic International Plc
relevant securities this form relates:
Use a separate form for each offeror/offeree

(d) Is the discloser the offeror or the offeree?    OFFEREE

(e) Date position held:                             08 June 2022
The latest practicable date prior to the disclosure

(f) In addition to the company in 1(c) above, is    NO
the discloser making disclosures in respect of any
other party to the offer?
If it is a cash offer or possible cash offer, state
“N/A”



2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates


Class of relevant security:                             Common Stock GBP 0.1

                                                         Interests     Short
                                                                      positions

                                                        Number    %   Number %

(1) Relevant securities owned and/or controlled:      10,552,454 1.43

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and
agreements to purchase/sell:

                                                      10,552,454 1.43
TOTAL:



All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b)        Rights to subscribe for new securities


Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:



3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE


Details of any interests, short positions and rights to subscribe (including
directors’ and other employee options) of any person acting in concert with the
party to the offer making the disclosure:


None



Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements


Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may be
an inducement to deal or refrain from dealing entered into by the party to the
offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state “none”

None



(b)        Agreements, arrangements or understandings relating to options or derivatives


Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer making the disclosure, or any person acting in
concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”

None



(c)        Attachments

Are any Supplemental Forms attached?


Supplemental Form 8 (Open Positions) NO

Supplemental Form 8 (SBL)            NO



   


Date of disclosure: 09 June 2022

Contact name:       Ian Gartshore

Telephone number:   020 3938 1825



Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk .